Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Any subject with Type 1 or Type 2 diabetes and accepting to use NovoPen® 4. The selection will be at the discretion of the individual physician.
A study specific signed informed consent must be signed by each subject before any study-related activities or information is collected, if required by local regulations
You may not be if
Subjects who are unlikely to comply with the protocol, e.g., unwillingness to cooperate, inability to return for the final visit
Subjects with known or suspected allergy to any insulin or any of its excipients
